The Prevalence and Determinants of Fusidic Acid Resistance Among Methicillin-Resistant Staphylococcus aureus Clinical

Huilin Zhao1, Xinyi Wang1, Bingjie Wang1

  • 1Department of Clinical Laboratory, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, China.

Frontiers in Medicine
|December 17, 2021
PubMed

Insights

Methicillin-resistant Staphylococcus aureus (MRSA) shows increasing resistance to fusidic acid (FA) in China, with significant geographic variations. High-level FA resistance is linked to fusA mutations, while fusB confers low-level resistance.

Area of Science:

  • Clinical Microbiology
  • Infectious Diseases
  • Molecular Epidemiology

Background:

  • Rising global concern over methicillin-resistant Staphylococcus aureus (MRSA) resistance to fusidic acid (FA).
  • Limited data on FA-resistant MRSA prevalence in China necessitates urgent investigation.

Purpose of the Study:

  • To determine the prevalence of FA resistance in MRSA isolates across China.
  • To identify the genetic determinants and molecular characteristics of FA-resistant MRSA.

Main Methods:

  • Antimicrobial susceptibility testing using disk diffusion and broth microdilution.
  • Whole-genome sequencing for resistance determinant identification and molecular typing.
  • Analysis of MRSA isolates from six tertiary hospitals (2016-2020).

Main Results:

  • Overall prevalence of FA-resistant MRSA was 16.2% (74/457), with significant regional differences (Hubei 40%, Sichuan 3.2%).
  • fusA mutations, particularly L461K, were found in 79.7% of resistant isolates, conferring high-level resistance.
  • The ST5-MRSA-II-t2460 clone was the predominant high-resistance strain, especially in Hubei.

Conclusions:

  • FA resistance in Chinese MRSA isolates is relatively high and geographically varied.
  • fusA mutations (especially L461K) are key drivers of high-level FA resistance.
  • The ST5-MRSA-II-t2460 clone significantly contributes to the spread of FA-resistant MRSA.